MacroGenics, Inc. (MGNX)
NASDAQ: MGNX · Real-Time Price · USD
3.180
+0.080 (2.58%)
Mar 17, 2026, 10:58 AM EDT - Market open

MacroGenics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-75.89-66.97-9.06-119.76-202.12-129.74
Depreciation & Amortization
7.527.549.6511.8711.2611.96
Stock-Based Compensation
22.8929.4418.3720.4423.1320.68
Other Adjustments
1.13-39.78-150.486.636.33-0.26
Change in Receivables
-60.486.0645.86-45.8412.7-10.34
Changes in Inventories
-8.92-2.190.230.06-6.42-
Changes in Accounts Payable
-0.78-1.531.28-10.867.133.72
Changes in Accrued Expenses
-1.565-4.82-4.64-0.616.99
Changes in Unearned Revenue
-13.01-9.4111.4348.829.26-8.47
Changes in Other Operating Activities
6.053.46-0.656.33-4.49-6.44
Operating Cash Flow
-162.47-68.37-78.21-86.96-143.83-111.9
Capital Expenditures
-2.29-3.71-1.76-3.62-6.2-5.91
Sale of Property, Plant & Equipment
0.040.160.06---
Purchases of Investments
-133.28-77.18-239.68-120.6-231.21-223.75
Proceeds from Sale of Investments
88.93190.03161.3194.94200.8221.87
Proceeds from Business Divestments
-40----
Investing Cash Flow
-6.64149.3-80.0870.72-36.61-7.79
Issuance of Common Stock
0.233.441.171.66122.78174.34
Repurchase of Common Stock
-0.29-2.48-0.31---
Net Common Stock Issued (Repurchased)
-0.060.960.861.66122.78174.34
Other Financing Activities
34.84-149.5---
Financing Cash Flow
69.610.96150.361.66122.78174.34
Net Cash Flow
-99.581.88-7.93-14.59-57.6654.66
Free Cash Flow
-164.76-72.08-79.97-90.58-150.03-117.8
FCF Margin
-129.10%-48.06%-136.12%-59.62%-193.72%-112.32%
Free Cash Flow Per Share
-2.61-1.15-1.29-1.47-2.50-2.25
Levered Free Cash Flow
-89.02-67.86.28-71.81-192.19-127.88
Unlevered Free Cash Flow
-128.31-112.99-152.9-73.47-192.87-129.2
Updated Nov 12, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q